(Q47929211)

English

High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).

scientific article published in October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8). (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

author name string

Y Heianza

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

Y Arase

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

K Fujihara

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

H Tsuji

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

K Saito

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

S D Hsieh

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

S Kodama

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

H Shimano

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

N Yamada

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

S Hara

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

29

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

1285-1290

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

The pros and cons of diagnosing diabetes with A1C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Two risk score models for predicting incident Type 2 diabetes in Japan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

What is the best predictor of future type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Loss of beta cell function as fasting glucose increases in the non-diabetic range

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Type 2 diabetes can be prevented with early pharmacological intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Preservation of β-cell function: the key to diabetes prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Epidemic obesity and type 2 diabetes in Asia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early beta-cell dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Subcutaneous thigh fat area is unrelated to risk of type 2 diabetes in a prospective study of Japanese Americans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03667.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2012.03667.X

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22486679

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47929211&oldid=2176005762"